| 000 | 01794nam a22005057a 4500 | ||
|---|---|---|---|
| 008 | 130224s20132013 xxu||||| |||| 00| 0 eng d | ||
| 040 | _aOvid MEDLINE(R) | ||
| 099 | _a23986488 | ||
| 245 | _aVemurafenib-induced DRESS. | ||
| 251 | _aJAMA Dermatology. 149(10):1242-3, 2013 Oct. | ||
| 252 | _aJAMA Dermatol.. 149(10):1242-3, 2013 Oct. | ||
| 253 | _aJAMA dermatology | ||
| 260 | _c2013 | ||
| 260 | _fFY2014 | ||
| 266 | _d2014-02-24 | ||
| 546 | _aEnglish | ||
| 650 | _a*Antineoplastic Agents/ae [Adverse Effects] | ||
| 650 | _a*Drug Hypersensitivity Syndrome/et [Etiology] | ||
| 650 | _a*Indoles/ae [Adverse Effects] | ||
| 650 | _a*Sulfonamides/ae [Adverse Effects] | ||
| 650 | _aAged, 80 and over | ||
| 650 | _aAntineoplastic Agents/tu [Therapeutic Use] | ||
| 650 | _aDrug Hypersensitivity Syndrome/pp [Physiopathology] | ||
| 650 | _aFemale | ||
| 650 | _aHumans | ||
| 650 | _aIndoles/tu [Therapeutic Use] | ||
| 650 | _aMelanoma/dt [Drug Therapy] | ||
| 650 | _aProtein Kinase Inhibitors/ae [Adverse Effects] | ||
| 650 | _aProtein Kinase Inhibitors/tu [Therapeutic Use] | ||
| 650 | _aProto-Oncogene Proteins B-raf/ai [Antagonists & Inhibitors] | ||
| 650 | _aSkin Neoplasms/dt [Drug Therapy] | ||
| 650 | _aSulfonamides/tu [Therapeutic Use] | ||
| 651 | _aMedStar Washington Hospital Center | ||
| 651 | _aWashington Cancer Institute | ||
| 656 | _aDermatology | ||
| 657 | _aCase Reports | ||
| 657 | _aJournal Article | ||
| 700 | _aJang, Sekwon | ||
| 700 | _aNasabzadeh, Teresa | ||
| 700 | _aPichard, Dominique C | ||
| 700 | _aWenk, Kurt S | ||
| 790 | _aJang S, Nasabzadeh T, Pichard DC, Venna SS, Wenk KS | ||
| 856 |
_uhttp://dx.doi.org/10.1001/jamadermatol.2013.5278 _zhttp://dx.doi.org/10.1001/jamadermatol.2013.5278 |
||
| 942 |
_cART _dArticle |
||
| 999 |
_c1455 _d1455 |
||